Adicet Bio Inc (NASDAQ: ACET) on Monday, soared 4.27% from the previous trading day, before settling in for the closing price of $0.72. Within the past 52 weeks, ACET’s price has moved between $0.45 and $1.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 18.90%. With a float of $65.38 million, this company’s outstanding shares have now reached $82.71 million.
Let’s look at the performance matrix of the company that is accounted for 152 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Adicet Bio Inc (ACET) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Adicet Bio Inc is 20.96%, while institutional ownership is 49.04%. The most recent insider transaction that took place on Jun 05 ’24, was worth 8,437. In this transaction Director of this company sold 5,900 shares at a rate of $1.43, taking the stock ownership to the 5,900 shares.
Adicet Bio Inc (ACET) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 18.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.90% during the next five years compared to 36.74% growth over the previous five years of trading.
Adicet Bio Inc (NASDAQ: ACET) Trading Performance Indicators
Adicet Bio Inc (ACET) is currently performing well based on its current performance indicators. A quick ratio of 9.34 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.29, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -0.86 in one year’s time.
Technical Analysis of Adicet Bio Inc (ACET)
Adicet Bio Inc (NASDAQ: ACET) saw its 5-day average volume 0.59 million, a negative change from its year-to-date volume of 0.73 million. As of the previous 9 days, the stock’s Stochastic %D was 68.94%. Additionally, its Average True Range was 0.07.
During the past 100 days, Adicet Bio Inc’s (ACET) raw stochastic average was set at 46.96%, which indicates a significant decrease from 74.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 121.30% in the past 14 days, which was higher than the 108.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6640, while its 200-day Moving Average is $1.0246. Nevertheless, the first resistance level for the watch stands at $0.7932 in the near term. At $0.8374, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8848. If the price goes on to break the first support level at $0.7016, it is likely to go to the next support level at $0.6542. Assuming the price breaks the second support level, the third support level stands at $0.6100.
Adicet Bio Inc (NASDAQ: ACET) Key Stats
Market capitalization of the company is 61.95 million based on 82,710K outstanding shares. Right now, sales total 0 K and income totals -117,120 K. The company made 0 K in profit during its latest quarter, and -28,210 K in sales during its previous quarter.
